Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iradimed (IRMD) Non Operating Income (2016 - 2026)

Iradimed has reported Non Operating Income over the past 14 years, most recently at $532000.0 for Q1 2026.

  • Quarterly Non Operating Income rose 3.7% to $532000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Mar 2026, down 4.12% year-over-year, with the annual reading at $2.2 million for FY2025, 4.16% down from the prior year.
  • Non Operating Income was $532000.0 for Q1 2026 at Iradimed, down from $696804.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $696804.0 in Q4 2025 and troughed at -$14915.0 in Q1 2022.
  • The 5-year median for Non Operating Income is $503192.0 (2023), against an average of $430054.6.
  • The largest YoY upside for Non Operating Income was 11343.59% in 2022 against a maximum downside of 163.38% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $449733.0 in 2022, then rose by 16.03% to $521810.0 in 2023, then grew by 4.14% to $543428.0 in 2024, then increased by 28.22% to $696804.0 in 2025, then dropped by 23.65% to $532000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Non Operating Income are $532000.0 (Q1 2026), $696804.0 (Q4 2025), and $463976.0 (Q3 2025).